Almost every coverage question comes down to which part pays, so it helps to have the map before the details:
- Part A — inpatient hospital care. Relevant if a procedure requires an overnight hospital admission.
- Part B — outpatient and physician services: specialist visits, surgery done on an outpatient basis, durable medical equipment, and occupational and physical therapy. This is where most tremor treatment sits. Part B pays 80% of the approved amount after the annual deductible; you pay the other 20% (Medicare.gov).
- Part C (Medicare Advantage) — a private plan that bundles Parts A and B (and usually drug coverage) together. It must cover everything Original Medicare does, but it uses provider networks and its own prior-authorization rules — and, unlike Original Medicare, it caps your yearly out-of-pocket spending.
- Part D — prescription drugs, through a stand-alone plan or built into an Advantage plan.
- Medigap — optional supplemental insurance that pays the coinsurance and deductibles Original Medicare leaves you with. As the quote above hints, there is a one-time window when you can buy it without medical underwriting; miss it and a plan can charge more or turn you down.
DBS is well established under Medicare. The national coverage rule that governs it — NCD 279, updated with an effective date of January 9, 2026 — covers thalamic (VIM) stimulation for essential tremor and Parkinson's tremor, and STN or GPi stimulation for Parkinson's disease (CMS NCD 279).
Coverage is conditional, not automatic. In broad terms, the tremor has to be severe and disabling, medication has to have been tried and found inadequate, and you have to be a suitable surgical candidate. Medicare specifically will not cover DBS where there is significant cognitive impairment, unstable psychiatric illness, substance use disorder, or other conditions that make the surgery unsafe or unlikely to help (CMS NCD 279). The device, the surgery and the ongoing programming visits are covered; your share is the Part B 20% coinsurance (or a hospital charge under Part A if you are admitted overnight).
This is the area where old information does the most harm. For years, MR-guided focused ultrasound — an incisionless procedure that treats tremor without implanting anything — was frequently not covered, and patients reported paying fifteen to twenty thousand dollars out of pocket. That has changed.
As of 2026, Original Medicare covers MRgFUS under Part B in all states (local coverage determination L37729) for medication-refractory essential tremor or tremor-dominant Parkinson's disease, with the standard 20% coinsurance (CMS LCD L37729). If you were told years ago that focused ultrasound wasn't an option because of cost, that advice is now out of date for Medicare beneficiaries. Two caveats remain: coverage is for people whose tremor hasn't responded to medication, and private (non-Medicare) insurers still vary — some continue to label focused ultrasound "experimental," so if you're not on Medicare, confirm your own plan's position before scheduling.
The drugs used for tremor — propranolol and primidone for essential tremor, and carbidopa-levodopa, dopamine agonists and others for Parkinson's — are covered under a Part D prescription drug plan. What you pay depends on your specific plan's formulary and its tier for each drug, and some medications require prior authorization or step therapy before the plan will pay.
The headline improvement for 2026 is a hard $2,100 annual cap on out-of-pocket costs for covered Part D drugs — once your spending reaches that amount, covered medications cost you nothing for the rest of the year (Medicare.gov). Two practical warnings sit alongside it. First, a drug only counts if it's on your plan's formulary, so if you take a specific branded Parkinson's medication, check that it's listed before you enroll — and if it isn't, ask about the formulary-exception process. Second, a handful of newer treatments are given by infusion and billed under Part B, not Part D; those fall outside the drug cap and carry the 20% coinsurance instead, which on a high-cost therapy can be a large yearly sum.
Rehabilitation is often the most underused covered benefit. Occupational therapy, physical therapy and speech therapy are covered under Part B at 80% after the deductible, and the old annual "therapy cap" no longer applies — therapy continues as long as it's medically necessary (Medicare.gov). For a tremor, an occupational therapist is often the highest-value, lowest-risk referral you can get covered.
On devices, Part B covers durable medical equipment that's medically necessary and prescribed. One tremor-specific example: a prescription wrist-worn nerve-stimulation device (TAPS therapy) is covered under Part B (local coverage determination L39591) for essential tremor, limited to a single dominant-hand device, with the usual 80/20 cost-sharing (CMS LCD L39591). Note the limits: that device coverage is for essential tremor rather than Parkinson's, and it's a prescription item subject to the eligibility criteria, not an automatic benefit. Many everyday assistive tools — weighted or adaptive utensils and the like — are inexpensive but generally not reimbursed, since they don't meet Medicare's definition of durable medical equipment.
The recurring theme is not whether a treatment is covered but how much of the remainder falls on you. A few moves genuinely change the math:
- Add a Medigap policy during your guaranteed-issue window. It pays the Part B coinsurance that otherwise has no ceiling — and, as the patient quote above learned, buying it late can mean higher premiums or denial. This is the single most consequential decision for a chronic condition.
- Compare Part D formularies for your exact drugs. Plans differ on which tremor and Parkinson's medications they cover and at what tier; the cheapest premium can be the most expensive plan if your drug sits on a high tier or isn't listed.
- Ask about Extra Help. The federal Extra Help (Low-Income Subsidy) program lowers Part D drug costs for people who qualify by income and assets.
- Use the appeals process when a claim is denied. A denial is not the end — Medicare and Advantage plans both have formal appeal levels, and a letter of medical necessity from your neurologist often changes the outcome, especially for a formulary exception.
- Look into foundation assistance. National tremor and Parkinson's organizations, and manufacturer patient-assistance programs, can help with costs that insurance leaves behind.
None of this is a substitute for confirming the specifics with Medicare or your plan before you commit to a treatment — coverage rules carry conditions, and the details of your own plan matter. But the broad picture in 2026 is more encouraging than the online rumor mill suggests: the major tremor treatments are covered, the once-dreaded focused-ultrasound bill is now a Medicare benefit, and the biggest lever you control is the supplemental coverage you choose around them.